Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Tetra Bio-Pharma
company
About
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug development for inflammation, pain, and more.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $4.50M
- Industries
- Biopharma,Cannabis,Health Care,Medical,Pharmaceutical
- Founded date
- May 17, 2007
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program.Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$4.50M
Tetra Bio-Pharma has raised a total of
$4.50M
in funding over 2 rounds. Their latest funding was raised on
Feb 16, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 16, 2022 | Post-IPO Debt | $4.50M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Tetra Bio-Pharma is funded by 1 investors.
Ministère de l'Économie et de l'Innovation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
